ODDITY Tech (ODD) Q4 2025 earnings review
Algorithm Shock Triggers Sudden Reversal in Growth Story
ODDITY delivered solid 24% revenue growth in Q4, capping off a record 2025, but the narrative completely reversed due to a severe dislocation with its largest advertising partner. Skyrocketing customer acquisition costs crushed Q4 margins and forced management to guide for a staggering 30% YoY revenue decline in 26Q1. While the underlying repeat business remains strong and the METHODIQ launch is underway, the broken top-of-funnel acquisition engine completely overshadows the Q4 beat. Management pulled full-year guidance, replacing certainty with hope for a second-half recovery.
🐂 Bull Case
The company holds $776 million in cash and investments with zero debt, plus newly secured $350 million credit facilities. This provides massive runway to fix algorithmic issues and aggressively execute the $103 million remaining buyback authorization.
Historically, over 60% of ODDITY's revenue comes from repeat purchases. If customer acquisition is temporarily frozen, this sticky cohort provides a critical revenue floor while top-of-funnel issues are repaired.
🐻 Bear Case
A single algorithmic change from one ad partner wiped out 30% of next quarter's revenue. This shatters the narrative that ODDITY's proprietary AI and data moat insulated it from standard e-commerce acquisition volatility.
The rising customer acquisition costs are already bleeding into profitability. Q4 Adjusted EBITDA margin compressed to 8.2% from 12.3% a year ago, reflecting severe inefficiencies in ad spend.
⚖️ Verdict: 🔴
Bearish. A 30% revenue drop guidance following an uninterrupted streak of 20%+ growth quarters is a severe shock. Management's reliance on external platform fixes to save the second half of 2026 leaves investors completely in the dark.
Key Themes
The AI Moat Illusion and CAC Crisis
Reversing. Management has spent years touting their proprietary AI, massive database of user images, and predictive tech as a structural moat that gave them "full control" over growth levers. However, a single algorithm change from an unnamed major ad partner diverted them to low-quality, high-cost auctions. This directly contradicts their prior narrative of marketing independence and reveals a critical, unhedged platform dependency that is paralyzing 26Q1 sales.
Profitability Squeeze
Decelerating. Adjusted EBITDA fell 17% YoY to $13 million in Q4, despite a 24% increase in revenue. The Adjusted EBITDA margin collapsed by 410 basis points down to 8.2%. The broken advertising funnel means ODDITY is spending significantly more to acquire fewer, lower-quality users, destroying near-term operating leverage.
Macro Backdrop and Gross Margin Strain
Decelerating. Gross margin dropped 220 basis points YoY in Q4 to 70.5%. Management previously brushed off macroeconomic headwinds and tariffs as easily manageable through efficiency and pricing power. The current data shows that supply chain costs and product mix shifts are compounding the top-line ad shock.
METHODIQ Launch Execution
Accelerating. The launch of METHODIQ in Q4 represents the company's ambitious pivot into the medical-grade skin and body market. Utilizing proprietary computer vision technology and AI models for acne grading, this telehealth platform is a primary driver for TAM expansion, assuming they can figure out how to market it efficiently.
Repeat Revenue Resilience
Stable. The direct-to-consumer model relies heavily on repeat customers. With the new user acquisition funnel currently impaired, ODDITY's survival and cash flow generation rely entirely on extracting lifetime value from existing IL MAKIAGE and SpoiledChild cohorts.
ODDITY LABS Commercialization
Stable. The company continues to shift from a pure software/marketing play to a biotech pipeline. Expanding ODDITY LABS to develop proprietary molecules offers a long-term path to high-efficacy product differentiation, reducing reliance on standard cosmetic formulations.
Other KPIs
Decelerating. Operating cash flow dropped 36% from $137.8 million in FY24, despite higher net income. This decline was driven heavily by working capital changes, particularly a $35.4 million increase in inventories to support the METHODIQ launch and preempt tariff risks.
Accelerating. SG&A spiked 23% YoY, consuming 69.4% of total revenue in Q4. This largely reflects the aborted or highly inefficient marketing spend associated with the ad platform algorithm dislocation, combined with the fixed costs of launching a new brand.
Guidance
Reversing. A catastrophic drop from the +27% growth seen in 25Q1 and +24% in 25Q4. The entire decline is attributed to the ad platform algorithm dislocation. Management withdrew standard full-year guidance, stating they will issue it in the coming months once visibility improves.
Key Questions
Platform Dependency details
Which specific platform (Meta, TikTok, Google) caused this dislocation, and what specific architectural or spending changes are being implemented to diversify away from this single point of failure?
Share Repurchase Execution
With the stock likely to face severe pressure from the Q1 guidance and $776 million in cash on the balance sheet, will management aggressively execute the remaining $103 million buyback authorization immediately?
METHODIQ Launch Impact
How much of the Q4 margin compression was a direct result of the advertising dislocation versus the planned initial launch costs and lower gross margins of the METHODIQ telehealth platform?